Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat

Basic fibroblast growth factor (bFGF) is a potent neurotrophic and vasoactive peptide. Previous studies have shown that intraventricularly-administered bFGF reduces the size of cerebral infarcts following focal ischemia. In the current study, we tested the effects of intravenously-administered bFGF in a model of focal ischemia/reperfusion. The right middle cerebral artery of mature male Wistar rats was occluded by intraluminal suture. After 2 h of occlusion, the suture was removed and intravenous infusion of bFGF in vehicle (45 micrograms/kg/h) or vehicle alone was begun, lasting 3 h. Animals were weighed and evaluated neurologically until sacrifice 7 days after ischemia. The volume of cerebral infarcts was then determined by H and E staining and image analysis. We found a 40% reduction in infarct volume in bFGF- vs. vehicle-treated rats (n = 11 vs. 11, P < 0.05). Reduction in infarct volume was associated with improved neurological outcome and regained body weight in bFGF-treated animals (both P < 0.05). No change in blood pressure was found during bFGF treatment. These results show that the delayed intravenous administration of bFGF reduces infarct size in this model of focal ischemia/reperfusion. The mechanisms of infarct reduction may include direct cytoprotective and/or vasoactive effects.

[1]  E. Kohmura,et al.  Basic Fibroblast Growth Factor Prevents Thalamic Degeneration after Cortical Infarction , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  S. Finklestein.  Growth Factors in Stroke , 1995 .

[3]  M. Mattson,et al.  Programmed Cell Life: Neuroprotective Signal Transduction and Ischemic Brain Injury , 1995 .

[4]  S. Finklestein,et al.  Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in Rats , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  K. Kogure,et al.  Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil , 1993, Brain Research.

[6]  Eugene M. Johnson,et al.  Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization , 1990, Neuron.

[7]  M. Chopp,et al.  Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat , 1993, Journal of the Neurological Sciences.

[8]  J. Schwartz,et al.  Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. , 1994, Cancer research.

[9]  K. Maiese,et al.  Regulation of Neuronal Vulnerability to Ischemia by Peptide Growth Factors and Intracellular Second Messenger Systems: The Role of Protein Kinase C and the cAMP Dependent Protein Kinase , 1995 .

[10]  M. Ginsberg,et al.  The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.

[11]  M. Klagsbrun,et al.  Purification and assay of intact human basic fibroblast growth factor using heparin-sepharose chromatography , 1986 .

[12]  S. Finklestein.  The potential use of neurotrophic growth factors in the treatment of cerebral ischemia. , 1996, Advances in neurology.

[13]  Michael Chopp,et al.  Distribution of the 72‐kd Heat‐Shock Protein as a Function of Transient Focal Cerebral Ischemia in Rats , 1992, Stroke.

[14]  S. Finklestein,et al.  Journal of Cerebral Blood Flow and Metabolism Basic Fibroblast Growth Factor Protects against Hypoxia-ischemia and Nmda Neurotoxicity in Neonatal Rats , 2022 .

[15]  W. Cowan,et al.  Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Robert E. Anderson,et al.  Treatment with basic fibroblastic growth factor following focal cerebral ischemia does not prevent neuronal injury , 1995, Journal of the Neurological Sciences.

[17]  P. Cuevas,et al.  Hypotensive activity of fibroblast growth factor. , 1991, Science.

[18]  M. Linnik,et al.  Evidence Supporting a Role for Programmed Cell Death in Focal Cerebral Ischemia in Rats , 1993, Stroke.

[19]  A. Yamadori,et al.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke , 1992, Neurology.

[20]  M Chopp,et al.  The Effect of Hypothermia on Transient Middle Cerebral Artery Occlusion in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Perez-polo,et al.  Nerve growth factor effects on pyridine nucleotides after oxidant injury of rat pheochromocytoma cells , 1992, Brain Research.

[22]  P. Walicke.  Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[25]  D. Gospodarowicz,et al.  Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries , 1986, Journal of cellular physiology.

[26]  M. Chopp,et al.  Neuronal survival is associated with 72-kDa heat shock protein expression after transient middle cerebral artery occlusion in the rat , 1993, Journal of the Neurological Sciences.

[27]  Y. Li,et al.  Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  S. Finklestein,et al.  Basic Fibroblast Growth Factor Protects Cerebrocortical Neurons Against Excitatory Amino Acid Toxicity In Vitro , 1993, Stroke.

[29]  B. Will,et al.  Effects of basic fibroblast growth factor (bFGF) on choline acetyltransferase activity and astroglial reaction in adult rats after partial fimbria transection , 1989, Neuroscience Letters.

[30]  K. Hossmann.  Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[31]  Robert E. Anderson,et al.  Intraventricular infusion of HBGF-2 promotes cerebral angiogenesis in Wistar rat , 1990, Brain Research.

[32]  M. Moskowitz,et al.  Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats , 1994, Annals of neurology.

[33]  Ed A. Cristostomo.  Neurological disorders: Novel experimental and therapeutic strategies By Laszlo Vecsei, Andrew Freese, Kenton J. Swartz and M. Flint Beal (eds.), 1992, Ellis Harwood Ltd., West Sussex, 73 pp., hard cover, $85.00, ISBN 0-13-617184-2 , 1993, Journal of the Neurological Sciences.

[34]  M. Klagsbrun.  The fibroblast growth factor family: structural and biological properties. , 1989, Progress in growth factor research.

[35]  W. Pulsinelli,et al.  Transient global ischemia induces dynamic changes in the expression of bFGF and the FGF receptor. , 1994, Brain research. Molecular brain research.

[36]  B. Pettmann,et al.  Purification of two astroglial growth factors from bovine brain , 1985, FEBS letters.

[37]  M. Moskowitz,et al.  Basic Fibroblast Growth Factor Dilates Rat Pial Arterioles , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  M. Mattson,et al.  Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. , 1994, Journal of neurotrauma.

[39]  M. Chopp,et al.  Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient (2h) but not after permanent MCA occlusion in the rat , 1994 .

[40]  L. Caplan.  Brain ischemia : basic concepts and clinical relevance , 1995 .

[41]  M. Chopp,et al.  Postischemic Administration of an Anti‐Mac‐1 Antibody Reduces Ischemic Cell Damage After Transient Middle Cerebral Artery Occlusion in Rats , 1994, Stroke.